Please enable JavaScript to continue using this application.

Compare $TENX vs $XBIT | Chartloom

Compare

$TENX vs $XBIT

Tenax Therapeutics Inc · XBiotech Inc

TENX

Tenax Therapeutics Inc

XBIT

XBiotech Inc

Compare $TENX vs $XBIT

Comparing Tenax Therapeutics Inc and XBiotech Inc

TENXTenax Therapeutics Inc

XBITXBiotech Inc

TENXTenax Therapeutics Inc

Market cap

$50M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-82.9%

YTD performance

-83.1%

52W performance

-76.1%

FCF yield

-92.8%

XBITXBiotech Inc

Market cap

$70M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.8%

52W performance

-14.9%

FCF yield

-58.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

TENX

XBIT

Detailed metrics comparison

TENX

Tenax Therapeutics Inc

XBIT

XBiotech Inc

Market Cap

TENX$50M

XBIT$70M

Enterprise Value

TENX$-68M

XBIT$-40M

Price

TENX$1.87

XBIT$2.29

P/E Ratio

TENXN/A

XBITN/A

P/S Ratio

TENX1,503.03x

XBIT16.50x

EV/Sales

TENX-889.99x

XBIT-10.81x

EV/EBITDA

TENX0.00x

XBIT-0.06x

P/B Ratio

TENX0.65x

XBIT0.52x

P/FCF Ratio

TENXN/A

XBITN/A

EV/FCF

TENX1.49x

XBIT0.97x

PEG Ratio

TENXN/A

XBITN/A

Forward P/E (NTM)

TENXN/A

XBITN/A

Forward P/S (NTM)

TENXN/A

XBITN/A

Revenue (TTM)

TENX$0

XBIT$0

Revenue Growth (YoY)

TENX-82.9%

XBITN/A

Forward Rev Growth

TENX111.9%

XBIT0.0%

Gross Margin (TTM)

TENX100.0%

XBIT83.8%

Operating Margin (TTM)

TENX0.0%

XBIT0.0%

EBITDA Margin (TTM)

TENX0.0%

XBIT0.0%

Net Margin (TTM)

TENX0.0%

XBIT0.0%

FCF Margin (TTM)

TENXN/A

XBITN/A

Net Income (TTM)

TENX$-65M

XBIT$-45M

FCF (TTM)

TENX$-46M

XBIT$-41M

EPS (TTM)

TENX-$1.28

XBIT-$1.48

ROE (TTM)

TENX-6155.0%

XBIT-3162.0%

ROA (TTM)

TENX-5742.0%

XBIT-3029.0%

ROIC (TTM)

TENX-6155.0%

XBIT-3162.0%

Cash

TENX$118M

XBIT$110M

Debt

TENX$0

XBIT$0

Net Cash/Debt

TENX$118M

XBIT$110M

Current Ratio (TTM)

TENX15.07x

XBIT33.15x

Quick Ratio (TTM)

TENX14.65x

XBIT32.75x

Debt/Equity (TTM)

TENX0.00x

XBIT0.00x

Debt/Assets (TTM)

TENX0.0%

XBIT0.0%

Interest Coverage (TTM)

TENXN/A

XBITN/A

Net Debt/EBITDA (TTM)

TENX0.00x

XBIT0.00x

Beta

TENX1.00

XBIT0.73

52W Performance

TENX-76.1%

XBIT-14.9%

YTD Performance

TENX-83.1%

XBIT-3.8%

% from 52W High

TENX-90.4%

XBIT-33.4%

% from 52W Low

TENX42.7%

XBIT9.6%

Asset Turnover (TTM)

TENX0.00x

XBIT0.02x

FCF Yield (TTM)

TENX-92.8%

XBIT-58.5%

Earnings Yield (TTM)

TENX-130.7%

XBIT-64.6%

Dividend Yield (TTM)

TENXN/A

XBITN/A

Rule of 40

TENX-82.9

XBIT0.0

EV/GP/RG

TENXN/A

XBITN/A

Ticker research

View TENX research View XBIT research

Metric	TENX Tenax Therapeutics Inc	XBIT XBiotech Inc
Market & Valuation
Market Cap	$50M	$70M
Enterprise Value	$-68M	$-40M
Price	$1.87	$2.29
P/E Ratio	N/A	N/A
P/S Ratio	1,503.03x	16.50x
EV/Sales	-889.99x	-10.81x
EV/EBITDA	0.00x	-0.06x
P/B Ratio	0.65x	0.52x
P/FCF Ratio	N/A	N/A
EV/FCF	1.49x	0.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-82.9%	N/A
Forward Rev Growth	111.9%	0.0%
Profitability
Gross Margin (TTM)	100.0%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-65M	$-45M
FCF (TTM)	$-46M	$-41M
EPS (TTM)	-$1.28	-$1.48
ROE (TTM)	-6155.0%	-3162.0%
ROA (TTM)	-5742.0%	-3029.0%
ROIC (TTM)	-6155.0%	-3162.0%
Financial Health
Cash	$118M	$110M
Debt	$0	$0
Net Cash/Debt	$118M	$110M
Current Ratio (TTM)	15.07x	33.15x
Quick Ratio (TTM)	14.65x	32.75x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.00	0.73
52W Performance	-76.1%	-14.9%
YTD Performance	-83.1%	-3.8%
% from 52W High	-90.4%	-33.4%
% from 52W Low	42.7%	9.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-92.8%	-58.5%
Earnings Yield (TTM)	-130.7%	-64.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-82.9	0.0
EV/GP/RG	N/A	N/A
Ticker research	View TENX research	View XBIT research

Valuation

P/S Ratio

XBIT

16.50x

TENX

1,503.03x

EV/FCF

XBIT

0.97x

TENX

1.49x

Growth & revenue

Revenue Growth TTM

TENX

-82.9%

Forward Revenue Growth

TENX

111.9%

XBIT

0.0%

Profitability & performance

Gross Margin

TENX

100.0%

XBIT

83.8%

ROE

XBIT

-3162.0%

TENX

-6155.0%

FCF Yield %

XBIT

-58.5%

TENX

-92.8%

52-Week Performance

XBIT

-14.9%

TENX

-76.1%

Detailed metrics comparison

TENX

Tenax Therapeutics Inc

XBIT

XBiotech Inc

Market Cap

TENX$50M

XBIT$70M

Enterprise Value

TENX$-68M

XBIT$-40M

Price

TENX$1.87

XBIT$2.29

P/E Ratio

TENXN/A

XBITN/A

P/S Ratio

TENX1,503.03x

XBIT16.50x

EV/Sales

TENX-889.99x

XBIT-10.81x

EV/EBITDA

TENX0.00x

XBIT-0.06x

P/B Ratio

TENX0.65x

XBIT0.52x

P/FCF Ratio

TENXN/A

XBITN/A

EV/FCF

TENX1.49x

XBIT0.97x

PEG Ratio

TENXN/A

XBITN/A

Forward P/E (NTM)

TENXN/A

XBITN/A

Forward P/S (NTM)

TENXN/A

XBITN/A

Revenue (TTM)

TENX$0

XBIT$0

Revenue Growth (YoY)

TENX-82.9%

XBITN/A

Forward Rev Growth

TENX111.9%

XBIT0.0%

Gross Margin (TTM)

TENX100.0%

XBIT83.8%

Operating Margin (TTM)

TENX0.0%

XBIT0.0%

EBITDA Margin (TTM)

TENX0.0%

XBIT0.0%

Net Margin (TTM)

TENX0.0%

XBIT0.0%

FCF Margin (TTM)

TENXN/A

XBITN/A

Net Income (TTM)

TENX$-65M

XBIT$-45M

FCF (TTM)

TENX$-46M

XBIT$-41M

EPS (TTM)

TENX-$1.28

XBIT-$1.48

ROE (TTM)

TENX-6155.0%

XBIT-3162.0%

ROA (TTM)

TENX-5742.0%

XBIT-3029.0%

ROIC (TTM)

TENX-6155.0%

XBIT-3162.0%

Cash

TENX$118M

XBIT$110M

Debt

TENX$0

XBIT$0

Net Cash/Debt

TENX$118M

XBIT$110M

Current Ratio (TTM)

TENX15.07x

XBIT33.15x

Quick Ratio (TTM)

TENX14.65x

XBIT32.75x

Debt/Equity (TTM)

TENX0.00x

XBIT0.00x

Debt/Assets (TTM)

TENX0.0%

XBIT0.0%

Interest Coverage (TTM)

TENXN/A

XBITN/A

Net Debt/EBITDA (TTM)

TENX0.00x

XBIT0.00x

Beta

TENX1.00

XBIT0.73

52W Performance

TENX-76.1%

XBIT-14.9%

YTD Performance

TENX-83.1%

XBIT-3.8%

% from 52W High

TENX-90.4%

XBIT-33.4%

% from 52W Low

TENX42.7%

XBIT9.6%

Asset Turnover (TTM)

TENX0.00x

XBIT0.02x

FCF Yield (TTM)

TENX-92.8%

XBIT-58.5%

Earnings Yield (TTM)

TENX-130.7%

XBIT-64.6%

Dividend Yield (TTM)

TENXN/A

XBITN/A

Rule of 40

TENX-82.9

XBIT0.0

EV/GP/RG

TENXN/A

XBITN/A

Ticker research

View TENX research View XBIT research

Metric	TENX Tenax Therapeutics Inc	XBIT XBiotech Inc
Market & Valuation
Market Cap	$50M	$70M
Enterprise Value	$-68M	$-40M
Price	$1.87	$2.29
P/E Ratio	N/A	N/A
P/S Ratio	1,503.03x	16.50x
EV/Sales	-889.99x	-10.81x
EV/EBITDA	0.00x	-0.06x
P/B Ratio	0.65x	0.52x
P/FCF Ratio	N/A	N/A
EV/FCF	1.49x	0.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-82.9%	N/A
Forward Rev Growth	111.9%	0.0%
Profitability
Gross Margin (TTM)	100.0%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-65M	$-45M
FCF (TTM)	$-46M	$-41M
EPS (TTM)	-$1.28	-$1.48
ROE (TTM)	-6155.0%	-3162.0%
ROA (TTM)	-5742.0%	-3029.0%
ROIC (TTM)	-6155.0%	-3162.0%
Financial Health
Cash	$118M	$110M
Debt	$0	$0
Net Cash/Debt	$118M	$110M
Current Ratio (TTM)	15.07x	33.15x
Quick Ratio (TTM)	14.65x	32.75x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.00	0.73
52W Performance	-76.1%	-14.9%
YTD Performance	-83.1%	-3.8%
% from 52W High	-90.4%	-33.4%
% from 52W Low	42.7%	9.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-92.8%	-58.5%
Earnings Yield (TTM)	-130.7%	-64.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-82.9	0.0
EV/GP/RG	N/A	N/A
Ticker research	View TENX research	View XBIT research